Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 9, 2025Circulation Research

Abstract Wed044: Dynamic Regulation and Functional Role of HSPB7 in Pathological and Physiological Cardiac Hypertrophy in vitro and in vivo

View Full Paper
Ask AI
Bookmark
Share

Authors

MQMeixi QuanQZQiulian ZhouJGJ. Sawalla Guseh

Discussion

Loading...

Member takes

Overview

Dynamic regulation of hspb7 influences cardiac hypertrophy outcomes, suggesting therapeutic potential.

Key Points

  • HSPB7 overexpression mitigated pathological hypertrophy, improving cardiac function in vivo after TAC.
  • In pathological conditions, HSPB7 expression changes dynamically, highlighting its dual role in hypertrophy.
  • Functional studies showed that HSPB7 loss exacerbated mitochondrial dysfunction and pathological hypertrophy.
  • Proteomics identified binding partners linked to HSPB7's role in cardiac hypertrophy and heart health.

Cite This Study

Quan et al. (2025) studied this question.

synapsesocial.com/papers/68e80eb363e2e2f707877df3https://doi.org/10.1161/res.137.suppl_1.wed044
View Full Paper
Ask AI
Bookmark
Share